Evofem Biosciences, Inc.
Qualité des données : 100%
EVFM
OTC
Manufacturing
Chemicals
0,01 €
0,00 €
(0,00%)
6 months return
—
Momentum
Neutral
5Y revenue growth
25,09%
Croissance
Revenue Growth (5Y)
25,09%
Au-dessus de la moyenne du secteur (1,82%)
Revenue (1Y)4,23%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
N/A
ROICN/A
Net Margin1,94%
Op. Margin16,71%
Sécurité
Debt / Equity
N/A
Current Ratio0,10
Interest Coverage1,43
Valorisation
PE (TTM)
2,88
Au-dessus de la moyenne du secteur (-1,50)
P/B RatioN/A
EV/EBITDA0,42
Dividend YieldN/A
Quick Summary
Key Takeaways
Short bullets derived from reported financials—not the AI summary above.
Revenue grew 25,09% annually over 5 years — strong growth
Negative free cash flow of -2,00 M
P/E of 2,88 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 20,86%
Capital efficient — spends only 0,02% of revenue on capex
Interest coverage of 1,43× — tight debt servicing
Price History
Tendances Financières
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Surprises de Résultats
EPS
Reported
Estimate
| Q42023 | |
|---|---|
| Reported | -0,44 € |
| Estimate | -0,61 € |
| Surprise | +27,87% |
Growth
Rev 5Y: 25,09% · Earnings 1Y: N/A
Growth
Rev 5Y: 25,09% · Earnings 1Y: N/A| Revenue Growth (1Y) | 4,23% | Revenue Growth (3Y) | 5,25% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | -91,41% |
| Revenue Growth (5Y) | 25,09% | Earnings Growth (5Y) | N/A |
Profitability
ROE: N/A · Net Margin: 1,94%
Profitability
ROE: N/A · Net Margin: 1,94%| Revenue (TTM) | 20,18 M | Net Income (TTM) | 391 000,0 |
| ROE | N/A | ROA | 2,77% |
| Gross Margin | N/A | Operating Margin | 16,71% |
| Net Margin | 1,94% | Free Cash Flow (TTM) | -2,00 M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
Safety
D/E: N/A · Current: 0,10
Safety
D/E: N/A · Current: 0,10| Debt / Equity | N/A | Current Ratio | 0,10 |
| Interest Coverage | 1,43 | Asset Turnover | 1,43 |
| Working Capital | -70,27 M | Tangible Book Value | -80,30 M |
Dividends
Yield: N/A · Payout: N/A
Dividends
Yield: N/A · Payout: N/A| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
Valuation
P/E: 2,88 · EV/EBITDA: 0,42
Valuation
P/E: 2,88 · EV/EBITDA: 0,42| P/E Ratio | 2,88 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | 0,06 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | 0,42 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -177,27% | ||
| Market Cap | 1,13 M | Enterprise Value | 1,42 M |
Per Share
EPS: 0,00 · FCF/Share: -0,02
Per Share
EPS: 0,00 · FCF/Share: -0,02| EPS (Diluted TTM) | 0,00 | Revenue / Share | 0,16 |
| FCF / Share | -0,02 | OCF / Share | -0,02 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
Efficiency
FCF Conv: -510,74% · CapEx/Rev: 0,02%
Efficiency
FCF Conv: -510,74% · CapEx/Rev: 0,02%| CapEx / Revenue | 0,02% | FCF Conversion | -510,74% |
| SBC-Adj. FCF | -2,32 M | Growth Momentum | -20,86 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 20,18 M | 19,36 M | 18,22 M | 16,84 M | 8,24 M |
| Net Income | 391 000,0 | -8,86 M | 52,98 M | -76,70 M | -205,19 M |
| EPS (Diluted) | 0,00 | -0,12 | 0,05 | -1,34 | -1,58 |
| Gross Profit | — | — | — | — | — |
| Operating Income | 3,37 M | -7,68 M | -17,85 M | -84,12 M | -166,80 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | 1,85 M | 2,94 M | 25,03 M | 33,13 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | 477 000,0 | 1,02 M | 1,02 M |
| Interest Expense | 2,37 M | 2,24 M | 2,27 M | 2,18 M | 2,67 M |
| Income Tax | 2 000,0 | 17 000,0 | 17 000,0 | 44 000,0 | 17 000,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 20,27 M | 23,79 M | 10,55 M | 25,16 M | 42,51 M |
| Total Liabilities | 89,71 M | 90,26 M | 72,47 M | 96,96 M | 142,09 M |
| Shareholders' Equity | -74,34 M | -71,26 M | -66,51 M | -71,80 M | -104,32 M |
| Total Debt | 147 000,0 | 135 000,0 | — | — | — |
| Cash & Equivalents | 578 000,0 | — | 2,77 M | 2,77 M | 7,73 M |
| Current Assets | 15,28 M | 13,61 M | 9,21 M | 12,70 M | 30,14 M |
| Current Liabilities | 84,82 M | 80,45 M | 72,46 M | 93,83 M | 137,66 M |
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1605 pairs)
Par rapport à des entreprises similaires dans Manufacturing
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1605 pairs) Par rapport à des entreprises similaires dans Manufacturing| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 2,9 | -1,5 |
| P/B | — | 1,6 |
| ROE % | — | -54,5 |
| Net Margin % | 1,9 | -41,5 |
| Rev Growth 5Y % | 25,1 | 1,8 |
| D/E | — | 0,3 |
{"event":"ticker_viewed","properties":{"ticker":"EVFM","listing_kind":"stock","pathname":"/stocks/evfm","exchange":"OTC","country":"US"}}